I reported previously (Dec 2013) on Israel’s VBL Therapeutics (aka Vascular Biogenics) and its treatment VB-111 for brain cancer. VB-111 targets new blood vessels developed to feed the tumor. Also, delivering the treatment inside a virus triggers the immune system to attack the tumor.

http://www.timesofisrael.com/israel-firm-has-high-hopes-for-new-cancer-busting-drug/